Login / Signup

Therapeutic effects of an oral gonadotropin-releasing hormone receptor antagonist, relugolix, on preventing premature ovulation in mild ovarian stimulation for IVF.

Kazuki NakaoKeiji KurodaTakashi HorikawaAzusa MoriyamaHiroyasu JuenAkiko ItakuraHideaki WatanabeSatoru TakamizawaYuko OjiroKoji NakagawaRikikazu Sugiyama
Published in: Reproductive medicine and biology (2021)
Although relugolix had a high ovulation suppressive effect, when the LH surge occurred, its effect was insufficient.
Keyphrases
  • polycystic ovary syndrome
  • insulin resistance
  • pregnancy outcomes
  • type diabetes
  • metabolic syndrome
  • pregnant women
  • skeletal muscle